Potential of the strain Raoultella sp. KDF8 for removal of analgesics
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
RVO61388971
Czech Acad Sci, Inst Microbiol
720414
Grant Agency of Charles University
TH02030337
Technology Agency of the Czech Republic
PubMed
29127620
DOI
10.1007/s12223-017-0563-2
PII: 10.1007/s12223-017-0563-2
Knihovny.cz E-resources
- Keywords
- Analgesics, Co-metabolism, Microbial degradation, Raoultella sp., Whole cell catalyst,
- MeSH
- Analgesics metabolism toxicity MeSH
- Water Pollutants, Chemical metabolism MeSH
- Diclofenac metabolism toxicity MeSH
- DNA, Bacterial genetics MeSH
- Enterobacteriaceae classification drug effects metabolism MeSH
- Phylogeny MeSH
- Codeine metabolism toxicity MeSH
- Hydrogen-Ion Concentration MeSH
- Microbial Viability drug effects MeSH
- Soil Microbiology MeSH
- RNA, Ribosomal, 16S genetics MeSH
- Temperature MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Analgesics MeSH
- Water Pollutants, Chemical MeSH
- Diclofenac MeSH
- DNA, Bacterial MeSH
- Codeine MeSH
- RNA, Ribosomal, 16S MeSH
The bacterial strain KDF8 capable of growth in the presence of diclofenac and codeine analgesics was obtained after chemical mutagenesis of nature isolates from polluted soils. The strain KDF8 was identified as Raoultella sp. based on its morphology, biochemical properties, and 16S rRNA gene sequence. It was deposited in the Czech Collection of Microorganisms under the number CCM 8678. A growing culture efficiently removed diclofenac (92% removal) and partially also codeine (about 30% degradation) from culture supernatants within 72 h at 28 °C. The degradation of six analgesics by the whole cell catalyst was investigated in detail. The maximum degradation of diclofenac (91%) by the catalyst was achieved at pHINI of 7 (1 g/L diclofenac). The specific removal rate at high concentrations of diclofenac and codeine increased up to 16.5 mg/gCDW per h and 5.1 mg/gCDW per h, respectively. HPLC analysis identified 4'-hydroxydiclofenac as a major metabolite of diclofenac transformation and 14-hydroxycodeinone as codeine transformation product. The analgesics ibuprofen and ketoprofen were also removed, albeit to a lower extent of 3.2 and 2.0 mg/gCDW per h, respectively. Naproxen and mefenamic acid were not degraded.
See more in PubMed
J Hazard Mater. 2016 Jan 15;301:443-52 PubMed
Mutat Res. 2007 Nov-Dec;636(1-3):178-242 PubMed
Appl Microbiol. 1975 Oct;30(4):650-6 PubMed
Environ Sci Technol. 2009 Feb 1;43(3):597-603 PubMed
Appl Microbiol. 1975 Aug;30(2):262-6 PubMed
Biodegradation. 2009 Jun;20(3):363-73 PubMed
Ecotoxicol Environ Saf. 2003 Jul;55(3):359-70 PubMed
Appl Environ Microbiol. 2005 Oct;71(10):6121-5 PubMed
Microbiology. 2013 Mar;159(Pt 3):621-32 PubMed
Sci Total Environ. 2011 Sep 15;409(20):4351-60 PubMed
Chemosphere. 2004 Aug;56(7):659-66 PubMed
Environ Sci Technol. 2010 Oct 1;44(19):7213-9 PubMed
Arch Microbiol. 1990;154(5):465-70 PubMed
Chemosphere. 2008 Nov;73(8):1151-61 PubMed
Int J Syst Evol Microbiol. 2001 May;51(Pt 3):925-32 PubMed
Biodegradation. 2015 Apr;26(2):105-13 PubMed
Methods Enzymol. 1991;204:114-25 PubMed
Chemosphere. 2007 Jan;66(6):993-1002 PubMed
Environ Pollut. 2012 May;164:267-73 PubMed
Trends Biotechnol. 2005 Apr;23(4):163-7 PubMed
Chemosphere. 2007 Sep;69(4):509-16 PubMed
Mol Biol Evol. 2016 Jul;33(7):1870-4 PubMed
N Biotechnol. 2015 Jan 25;32(1):147-56 PubMed
Biomed Res Int. 2013;2013:325806 PubMed
Chem Biol Interact. 2003 Oct 25;146(2):121-9 PubMed
Biodegradation. 2007 Feb;18(1):27-35 PubMed
Environ Int. 2014 Aug;69:28-39 PubMed
Prikl Biokhim Mikrobiol. 2006 May-Jun;42(3):292-7 PubMed
Microb Biotechnol. 2012 May;5(3):388-95 PubMed
Appl Environ Microbiol. 2001 May;67(5):2197-201 PubMed
Water Res. 2002 Oct;36(17):4307-18 PubMed
Biochem Pharmacol. 1999 Sep 1;58(5):787-96 PubMed
J Am Chem Soc. 2005 May 25;127(20):7286-7 PubMed
J Pharmacol Exp Ther. 2002 Dec;303(3):969-78 PubMed
Water Res. 2009 Feb;43(3):831-41 PubMed
Int J Hyg Environ Health. 2002 Jul;205(5):393-8 PubMed
Biotechnol Adv. 2009 Nov-Dec;27(6):686-714 PubMed